Yüklüyor......

LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia

ApoC-III is a proatherogenic protein associated with elevated triglycerides; its deficiency is associated with reduced atherosclerosis. Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases ca...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Brautbar, Ariel, Virani, Salim S., Belmont, John, Nambi, Vijay, Jones, Peter H., Ballantyne, Christie M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The American Society for Biochemistry and Molecular Biology 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276479/
https://ncbi.nlm.nih.gov/pubmed/22236405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M020404
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!